A Complement to Traditional Treatments for Antibody-Mediated Rejection? Use of Eculizumab in Lung Transplantation: A Review and Early Center Experience.
Hanna L KleiboekerAlyson PromKrista PaplaczykCatherine N MyersPublished in: The Annals of pharmacotherapy (2023)
Optimizing use of current therapies, as well as identifying and advancing novel therapeutic modalities such as eculizumab, are vital for the improvement of AMR prevention and treatment in LTRs to extend long-term allograft function and survival.